The international CAR T-cell therapy market is experiencing substantial growth, driven by increasing demand for cutting-edge cancer treatment options. This exponential expansion is fueled by elements such as the authorization of CAR T-cell therapies for diverse indications, advancements in production technologies, and expanding research and develop